Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastrointestinal epithelial tight junction (TJ) protein complex is a multi-protein assembly that regulates the paracellular pathway between adjacent epithelial cells, serving as the primary determinant of mucosal barrier integrity (PMID: 28588585). This complex consists of transmembrane proteins such as claudins, occludin, and junctional adhesion molecules (JAMs), which are anchored to the actin cytoskeleton via scaffolding proteins like zonula occludens-1 (ZO-1) (PMID: 19112273). The mucosal barrier, encompassing these junctions and the protective mucus layer, is critical for preventing the systemic translocation of luminal pathogens and antigens while allowing selective nutrient absorption (StatPearls, NBK557740). Impairment of this barrier, often termed "leaky gut," is implicated in the pathogenesis of various conditions, including inflammatory bowel disease (IBD), celiac disease, and irritable bowel syndrome (IBS) (PMID: 23644306). Therapeutic candidates like larazotide acetate target this complex by antagonizing zonulin, a protein that triggers tight junction disassembly, thereby restoring barrier function (PMID: 22730478). Other pharmacological approaches include the use of GLP-2 analogs and ClC-2 activators to promote the expression and proper localization of TJ proteins (PMID: 21421910, PMID: 25895839). Additionally, nutritional interventions such as glutamine and zinc carnosine have been shown to support the structural integrity of these junctions during physiological stress (PMID: 25472015).
Stabilization of the paracellular barrier by modulating the assembly of transmembrane proteins (claudins, occludin) and scaffolding proteins (ZO-1), or by antagonizing zonulin-induced junctional disassembly (PMID: 22730478, PMID: 21421910).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal epithelial tight junction protein complex (TJ proteins).